AlzeCure will host a breakfast seminar on Alzheimer’s Disease and our innovative therapeutic candidates ACD856 and ACD680 on January 13 at the JP Morgan 2026 meeting in San Francisco. This meeting is the world’s leading lifescience partnering & investor meeting. We at AlzeCure are looking forward to present our company & ongoing Alzheimer projects and meet with pharmaceuticals companies, partners & investors.
Hope to see you there.
Time: January 13 2026 at 8.00-8.45 am
Location: Business Sweden’s office at 100 Montgomery Street, floor 16, 94104 San Francisco
If you like to attend reach out to dimitrina.dimitrova@alzecurepharma.com before EOB 8 Jan.